Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)


In the era of increasing macrolide- and quinolone-resistant Mycoplasma genitalium (MG), we report the efficacy of 2 nonquinolone antimicrobials in patients with limited treatment options. Pristinamycin + doxycycline cured 75% (95% CI, 64%-85%), and minocycline cured 71% (95% CI, 54%-85%) of cases. These data provide useful estimates to inform clinical practice.

Original languageEnglish
Article numberofaa291
Number of pages4
JournalOpen Forum Infectious Diseases
Issue number8
Publication statusPublished - Aug 2020


  • Multidrug failure
  • Mycoplasma genitalium
  • Sexually transmitted infections
  • Treatment

Cite this